| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $35.1M | — | +16.8% |
| R&D Expense | $33.8M | — | -2.4% |
| SG&A Expense | $26.7M | — | -2.4% |
| Operating Income | -$26.8M | — | +19.5% |
| Pre-tax Income | -$22.4M | — | +4.4% |
| Income Tax | $1K | — | -97.2% |
| Net Income | -$22.4M | — | +4.6% |
| EPS (Basic) | -$1.02 | — | +63.2% |
| EPS (Diluted) | -$1.24 | — | +55.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $90.8M | +50.1% | +134.3% |
| Accounts Receivable | $23.4M | -10.8% | -33.7% |
| Inventory | $3.6M | -10.9% | -24.5% |
| Current Assets | $126.3M | +22.5% | +5.1% |
| Total Assets | $131.4M | +21.2% | +2.9% |
| Current Liabilities | $117.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.7M | — | +41.7% |
| Investing Cash Flow | $3.2M | — | -79.1% |
| Financing Cash Flow | $49.8M | — | — |
| +29.8% |
| Total Liabilities | $397.1M | -1.1% | +19.0% |
| Stockholders' Equity | -$265.6M | +9.3% | -29.0% |